Robbins LLP reminds investors of global cord blood company class action lead plaintiff deadline

SAN DIEGO, May 1, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder representative purchased or otherwise acquired Global Cord Blood Corporation (NYSE: :CO) Securities filed a class action lawsuit against all individuals and entities.

For more information, submit a form, email attorney Aaron Dumas, Jr., or call (800) 350-6003.

Allegation: Robbins LLP is investigating allegations that the board of directors of Global Cord Blood Corporation (CO) engaged in self-serving and conflicting transactions

The complaint alleges that during the Class Period, Defendants failed to disclose that: (i) Global Cord employed capital allocation strategies designed to reserve funds for Company insiders and related parties rather than for the benefit of Company stockholders; (ii) Global Cord decided to reject The multiple going private offers and transactions were nothing more than defendants' selfish and conflicting attempts to divert company funds to company insiders and related parties; (iii) as a result of defendant Kam and his entities' misappropriation of hundreds of millions of dollars from the company, Defendants fundamentally misrepresented to investors Global Cord's practices with respect to capital allocation, strategic investments, acquisitions and related-party transactions; (iv) as a result, the Company's public statements were materially false and misleading at all relevant times. As a result, the company's stock price fell, hurting investors.

3rd party advertising. Not an offer or recommendation by disclosures here or
Remove ads

What should we do now: You may be eligible to join the Global Cord Blood Corporation class action lawsuit. Shareholders who wish to serve as class plaintiffs must file a motion with the court by June 24, 2024. You do not have to be involved in the case to be eligible for compensation. If you choose to take no action, you may remain absent from the Class.For more information please click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins Law Firm: Some law firms that issued press releases on the matter did not actually file securities class action lawsuits; Robbins Law Firm did. As a recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been helping shareholders recover losses, improve corporate governance structures and hold corporate executives accountable for misconduct since 2002. More than $1 billion in compensation for shareholders.

To be notified when a class-action lawsuit against a global cord blood company is settled, or to receive free alerts when a company executive engages in misconduct, sign up Stock Watch today.

Lawyer advertising. Past results do not guarantee similar results.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *